Patent · US Active

Peptide-oligourea hybrid compounds

US11285219B2 · kind B2 · utility

0Cited by
1References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 16, 2020
Grant dateMar 29, 2022
Priority date
Expiry dateFeb 11, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present description relates to peptidomimetic foldamers, and their synthesis. In particular, the description provides peptide-amino urea hybrid peptidomimetic foldamers comprising an alpha amino acid peptide portion and an oligourea portion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.